Brawn Nutrition SARM LGD 4mg 60 Caps

Description

Brawn Nutrition SARM LGD 4mg 60 Caps

Brawn Nutrition SARM LGD 4mg 60 Caps is a specialist single-compound capsule product containing a declared 4 mg of LGD-4033 per capsule.

Each container provides 60 capsules and 60 declared servings. Available product specifications identify one capsule as a serving and list LGD-4033, commonly known as Ligandrol, as the principal declared compound.

What is LGD-4033?

LGD-4033, also known as Ligandrol, is an investigational, orally active, non-steroidal selective androgen receptor modulator, commonly abbreviated as SARM. It is not a vitamin, mineral or conventional sports-nutrition ingredient. Published clinical research has examined LGD-4033 in healthy volunteers, but this does not establish the safety, quality or effectiveness of an independently marketed commercial capsule product.

Commercial listings often associate LGD-4033 with muscle growth, increased strength, recovery and changes in body composition. These promotional statements should not be presented as guaranteed, medically approved or clinically established effects of this particular product.

Product specifications

• Brand: Brawn Nutrition
• Product name: SARM LGD
• Declared compound: LGD-4033
• Alternative name: Ligandrol
• Declared amount: 4 mg per capsule
• Package size: 60 capsules
• Declared servings: 60
• Serving size shown in available listings: 1 capsule
• Product form: capsules
• Compound category: investigational selective androgen receptor modulator

The complete ingredient panel, capsule shell, excipients, batch number, expiry date, storage requirements and warnings should always be verified against the physical packaging before publication or dispatch.

Product presentation and verification

Brawn Nutrition SARM LGD is supplied in a capsule container displaying the brand name, LGD designation and capsule count.

A complete catalogue listing should allow customers to verify:

• the Brawn Nutrition branding,
• the SARM LGD product name,
• the declared 4 mg specification,
• the 60-capsule package size,
• the complete ingredient panel,
• the batch and expiry details,
• the manufacturer or responsible operator,
• the condition of the original safety seal.

The original label should remain the primary source for final product specifications. A container should not be distributed when the seal is damaged, the label appears altered or the physical product differs from the online description.

Safety and regulatory information

LGD-4033 is an investigational SARM and is not an FDA-approved medicine or authorised conventional dietary-supplement ingredient. FDA materials identify products containing LGD-4033 and other SARMs as unapproved drugs when marketed for human performance or therapeutic purposes.

The FDA associates SARM products with potentially serious risks, including liver injury, cardiovascular complications, sexual dysfunction, infertility and an increased risk of heart attack or stroke. The presence of supplement-style packaging does not demonstrate regulatory approval, purity or safety.

Information for tested athletes

LGD-4033, also known as Ligandrol, is specifically included on the 2026 World Anti-Doping Agency Prohibited List. Athletes and other individuals subject to anti-doping controls should treat the product as prohibited at all times.

This description is provided solely for accurate product identification and catalogue-reference purposes. It does not contain dosage instructions, cycle guidance, stacking recommendations, medical advice or guarantees of physical or performance-related results.